SNC
EW icon

Stifel Nicolaus & Co’s Edwards Lifesciences EW Stock Holding History

Stifel Nicolaus & Co’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$936K Sell
80,658
-102
-0.1% -$1.19K 0.02% 687
2013
Q2 		$905K Buy
+80,760
New +$956K 0.02% 662

Other funds holding EW

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Stifel Nicolaus & Co's EW Position: Q3 2013 in Review

Stifel Nicolaus & Co reduced its Edwards Lifesciences (EW) stake by 0.13% in Q3 2013, selling an estimated $1.19K and leaving 80,658 shares worth $936K. The position accounts for 0.02% of the portfolio, ranked #687.

Stifel Nicolaus & Co first reported a position in EW in Q2 2013 and has held it in 2 quarters since. 409 funds tracked by Wall St. Rank hold EW as of Q3 2013.

  • Stifel Nicolaus & Co held 80,658 shares of Edwards Lifesciences worth $936K as of Q3 2013.
  • Stifel Nicolaus & Co sold 102 Edwards Lifesciences shares in Q3 2013, an estimated $1.19K.
  • Edwards Lifesciences made up 0.02% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #687 holding.
  • Stifel Nicolaus & Co first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 2 quarters since.
  • 409 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.